Replica exchange molecular dynamics simulation of the coordination of Pt(ii)-Phenanthroline to amyloid-β† by Turner, Matthew et al.
RSC Advances
PAPER
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
0 
O
ct
ob
er
 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
1/
5/
20
19
 3
:1
2:
12
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal  | View IssueReplica exchangSchool of Chemistry, Cardiﬀ University, Pa
platts@cardiﬀ.ac.uk; Tel: +44(0)-2920-8749
† Electronic supplementary informa
10.1039/c9ra04637b
Cite this: RSC Adv., 2019, 9, 35089
Received 20th June 2019
Accepted 24th October 2019
DOI: 10.1039/c9ra04637b
rsc.li/rsc-advances
This journal is © The Royal Society of Ce molecular dynamics simulation
of the coordination of Pt(II)-Phenanthroline to
amyloid-b†
Matthew Turner, Shaun T. Mutter, Oliver D. Kennedy-Britten and James A. Platts *
We report replica exchange molecular dynamics (REMD) simulations of the complex formed between
amyloid-b peptides and platinum bound to a phenanthroline ligand, Pt(phen). After construction of an
AMBER-style forceﬁeld for the Pt complex, REMD simulation employing temperatures between 270 and
615 K was used to provide thorough sampling of the conformational freedom available to the peptide.
We ﬁnd that the full length peptide Ab42, in particular, frequently adopts a compact conformation with
a large proportion of a- and 3,10-helix content, with smaller amounts of b-strand in the C-terminal
region of the peptide. Helical structures are more prevalent than in the metal-free peptide, while turn
and strand conformations are markedly less common. Non-covalent interactions, including salt-bridges,
hydrogen bonds, and p-stacking between aromatic residues and the phenanthroline ligand, are
common, and markedly diﬀerent from those seen in the amyloid-b peptides alone.Introduction
Alzheimer's disease (AD) is a devastating neurodegenerative
condition that poses major healthcare challenges. Signicant
hallmarks of AD include the death of neurons and their
connections in addition to the presence of insoluble plaques and
neurobrillary tangles.1 The amyloid cascade hypothesis2–7
suggests that aggregation of the amyloid-b (Ab) peptide into
soluble oligomers, brils and plaques is the main driver of AD,
whereas the metal ion hypothesis8–22 suggests that disruption of
metal ion homeostasis promotes Ab aggregation and onset of AD.
Barnham et al.23–26 demonstrated that Pt(phenanthroline)
and related complexes are able to bind Ab and inhibit bril
formation and Ab toxicity. They also noted that cisplatin has no
eﬀect on this process, indicating that the planar aromatic
ligands confer some specicity for Ab to the platinum
complexes. In addition, the aromatic ligands form stabilising
noncovalent interactions through p–p stacking with aromatic
residues such as Phe4, Tyr10, and/or His6, 13 or 14. Later work
by Ma et al.27,28 determined that the Pt(phen) complex prefer-
entially binds to His6 and His14 in Ab16. EPR data indicated
that Cu2+/Zn2+ remain bound to Ab in the presence of Pt(phen),
but that the copper/zinc binding sites are altered.
Despite the promise of Pt complexes as potential treatments for
AD, detailed structural data on their eﬀect on Ab is relatively
scarce. Streltsov et al.29 used a combination of EXAFS and densityrk Place, Cardiﬀ CF10 3AT, UK. E-mail:
50
tion (ESI) available. See DOI:
hemistry 2019functional theory (DFT) to conrm binding through His residues,
while our group has used DFT, semi-empirical and molecular
mechanics methods to examine Pt binding to model peptides.30–32
The intrinsically disordered nature of Abmeans that such studies
struggle to sample the full conformational exibility of the
peptide. To address this possible shortcoming, and to provide
further details of possible Pt(phen)–peptide interactions and the
eﬀect of metal coordination on peptide structure at a molecular
level, we performed replica-exchangemolecular dynamics (REMD)
simulations of the platinum complex interacting with both the N-
terminal Ab16 fragment and complete Ab42 peptides. REMD is
a popular means of improving the reliability and scope of MD
simulations, and has been used previously to enhance sampling of
possible conformations of the intrinsically disordered Ab
peptide.33–38 Application to metal binding to Ab are rare, but one
recent study showed howHamiltonian replica exchangemolecular
dynamics (H-REMD) enhances sampling of copper–Ab
complexes.39,40 Gaining understanding of how these complexes
interact with the Ab peptide may help explain the eﬀect of Pt-
coordination on conformational exibility of Ab, and hence
provide insight on their anti-AD activity.Computational methods
Ab peptides were constructed in extended conformations41
with appropriate residue protonation states for physiological
pH. Pt(II) was coordinated via His6 N3 and His14 N3, as iden-
tied by experimental and computational work and shown in
Scheme 1. Structures were subjected to short LowMode42
conformational searches to obtain reasonable starting
structures.RSC Adv., 2019, 9, 35089–35097 | 35089
Table 1 Pt-Ab16 and Pt-Ab42 RMSD statistics from room temperature
REMD trajectory (A˚)
RMSD Rg
Pt-Ab16 Pt-Ab42 Pt-Ab16 Pt-Ab42
Ave 3.63 10.55 9.17 11.67
SD 1.31 1.65 0.68 1.57
Max 7.63 15.51 11.14 26.31
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View Article OnlineREMD simulations were performed using the AMBER16
package.43 The AMBER ﬀ14SB forceeld parameter set44 was
used tomodel all standard amino acid residues; organic ligands
were modelled using GAFF.45 The bonded MCPB.py46 approach
was used for Pt(II). Here metal bonding parameters are derived
from B3LYP/6-31G(d) frequency calculations and RESP charges
for the metal-coordinating regions were obtained from the
same level of theory using Gaussian09.47 Both simulations
exponentially spanned the temperature range between 270 and
615 K: for Ab16, 10 replicas were used, while for the larger Ab42
16 replicas were used. REMD simulation parameters were ob-
tained using the online REMD temperature generator.48 For
each replica, 110 ns of REMD simulation was performed and
110 000 conformations collected. The rst 10 ns was treated as
equilibration, and the last 100 ns was used for data analysis,
following the procedure used by Yang & Teplow.33
The Generalised Born solvation model49–51 was used to solvate
all Pt(II)-Ab systems, since the use of implicit solvent model
enhances conformational sampling.52 REMD simulations were
carried out in the NVT ensemble, using a Langevin thermostat to
control temperature. Exchange between replicas was attempted
every 2 ps. SHAKE was used to constrain bonds to hydrogen.
Simulations were performed using a 2 fs integration time step.
Analysis of the trajectories was performed using CPPTRAJ v16.16
(ref. 53) and VMD 1.9.3.54 Secondary structure assignment was
made using the DSSP algorithm55 via CPPTRAJ. Salt bridges were
dened as any contact distance of less than 3.2 A˚ between oxygen
and nitrogen atoms in charged residues. Ramachandran maps
were made using MDplot.56 Clustering was performed using the
DBSCAN algorithm Ester et al.,57 using backbone RMSD as the
metric, with MinPoints ¼ 5 and 3 ¼ 0.8.Results and discussion
An AMBER style forceeld for Pt(phenanthroline) bound to Ab
through histidines was constructed using MCPB.py from resultsScheme 1 Coordination mode of Pt(phen)-Ab16.
35090 | RSC Adv., 2019, 9, 35089–35097of B3LYP/6-31G(d) optimisation, frequency and electrostatic
potential. This resulted in bonding parameters (reported as [r0,
k] in units of A˚ and kcal mol1 A˚2) of [2.06, 107] for Pt–Nphen
and [2.05, 127] for Pt–NHis, indicating slightly stronger bonds to
His than to phen. Angle parameters ([q0, k] in  and kcal mol
1
deg2) were [81, 169] for Nphen–Pt–Nphen, [89, 150] for NHis–Pt–
NHis, [95, 158] for Nphen–Pt–NHis in cis-arrangement, and [176,
167] for trans-Nphen–Pt–NHis, reecting the distortions from
purely square planar values required by the bidentate phenan-
throline ligand. Non-bonded parameters for Pt were charge ¼
+0.027 e, 3 ¼ 0.0031 kcal mol1 and s ¼ 1.266 A˚. Full details of
all forceeld parameters and the resulting coordination geom-
etry around Pt are available as ESI (Tables S1 and S2).†
Using this forceeld, REMD with 10 and 16 replicas for Pt-
Ab16 and Pt-Ab42, respectively, covering temperatures ranging
from 270 to 625 K ran successfully, with exchange frequencies
averaging 0.146 and 0.196 across all frames. Root mean square
deviation (RMSD) from the energy minimised starting point
reached maximal values of 9.5 and 28.9 A˚ for Pt-Ab16 and Pt-
Ab42, respectively. Similarly, the radius of gyration (Rg) reached
maximal values of 11.9 and 32.3 A˚. Averaged over the nal 100
ns for all replicas at all temperatures, mean RMSD was 5.0 and
13.6 A˚, while mean Rg was 9.3 and 17.2 A˚. For both peptides,
mean and maximum RMSD and Rg are signicantly larger for
the entire REMD ensemble than for the trajectory closest to 300
K (vide infra), indicating that the use of elevated temperatures in
the REMD ensemble ensured increased conformational
sampling over MD at a single temperature.
Table 1 reports mean and standard deviation of RMSD values
for trajectories closest to 300 K for both Pt-Ab16 (299.3 K) and
Pt-Ab42 (304.4 K). In both cases, the standard deviation of
around 1.5 A˚ indicates simulations reach a stable set of
congurations, and the maximum value reached is consider-
ably less than for the entire REMD ensemble, particularly in the
longer peptide where the maximum value in the 300 K trajectory
is around half the maximum total value. The relatively large
force constants for Pt–N bond stretching leads to stable coor-
dination of Pt(phen) to Ab (Table S1†), with Pt–NHis distances
both averaging 2.06  0.06 A˚ (ESI Table S2†).
Details of Rg for 300 K simulations of Ab16 and Ab42 are also
shown in Table 1. On average, Pt-Ab16 adopts a relatively
compact conformation at room temperature, with average Rg of
9.2 A˚. For comparison, Ab16 in an extended conformation has
Rg¼ 17 A˚, and as a-helix Rg¼ 9.2 A˚, while complexes with Cu, Fe
and Zn have average Rg between 7.2 and 7.6 A˚.58 The larger Rg forThis journal is © The Royal Society of Chemistry 2019
Fig. 1 RMSF values, by residue, from 300 K REMD trajectories. Pt is bound to H6 and H14 in both cases, with selected other residues shown for
clarity.
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View Article Onlinethese complexes reects the size of the phenanthroline ligand
(Rg ¼ 2.3 A˚): subtracting this from the overall Rg indicates Pt
induces conformations of Ab16 that are similar in compactness
to other transition metals, despite coordinating to only two
residues rather than four or ve. Ab42 also adopts a compact
conformation, its overall average Rg of 11.6 A˚ only slightly larger
than that for the free peptide (9.6 A˚59), when the size of the
Pt(phen) is taken into account. The possible role of non-
covalent interaction in maintaining such compact conforma-
tions is explored below.
The principal moments of the Rg tensor provide information
on the shape adopted throughout the trajectory. Full data are
provided in ESI (Table S3),† which show that on average both
peptides adopt prolate spheroidal geometry, with two small andThis journal is © The Royal Society of Chemistry 2019one large eigenvalues. These can be used to construct shape
descriptors,60 as has been done recently for Ab oligomerisation
pathways,61 in particular anisotropy that varies from 0 (ideal
linear chain) to 1 (fully symmetric). These values are on average
0.252 for Pt-Ab16 and 0.245 for Pt-Ab42, showing that both
peptides are highly anisotropic. The Rg tensors also highlight
the sampling of conformations that results from use of REMD,
for Pt-Ab42 in particular, where the largest value of the largest
eigenvalue reaches 650 A˚2, a value that corresponds to an
almost fully extended conformation (Fig. S2†).
Fig. 1 displays root mean square uctuation (RMSF) data by
residue for both peptides at room temperature (numerical data
is available in Table S4†). It is apparent that both N- and C-
termini are highly exible, while residues bound to Pt (His6RSC Adv., 2019, 9, 35089–35097 | 35091
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View Article Onlineand His14) are relatively immobile (RMSF 3.0/2.7 A˚ in Pt-Ab16,
5.2/4.6 A˚ in Pt-Ab42). This is not limited to the metal-
coordinating residues: residues from Asp7 to His13 also
exhibit relatively low RMSF. Flexibility is high in the central
hydrophobic region (CHC), i.e. Leu17 to Ala21, falls between
Gly25 and Ile32 with particularly low value for Gly29, then rises
again toward the C-terminus. Overall statistics for RMSF by
amino acid are reported in Table 2, showing that the longer
peptide is markedly more mobile. Table S4† also reports RMSF
values for the Pt atom and the phen ligand, which are again
notably larger for Pt-Ab42. The origin of this behaviour, and its
consequences for the conformations adopted by the full
peptide, are explored in more detail below.
The incidence of salt bridge interactions in Pt-Ab16 and Pt-
Ab42 are summarised in Fig. 3 (numerical data in Table S5†). In
the shorter peptide, C-terminal Lys16 forms almost no salt
bridges (occupancy < 0.5% of frames), whereas Arg5 forms these
stabilising interactions much more frequently. Glu3-Arg5 is
especially prevalent, occurring in 76% of frames, while inter-
actions with Asp1, Asp7 and Glu11 are present but rarer
(between 5 and 10% of simulation time). The low occupancy of
Asp1 salt bridges is in agreement with the large RMSF and Ca
contact distances noted above. Furthermore, the low incidence
of both the Asp7-Arg5 and Glu11-Arg5 interactions may be as
a result of the large Pt(phen) system binding to His6 and His14
that ank these charged sites. In Pt-Ab42, Arg5 again engages in
most salt bridges, most notably with Glu3 and Asp7, but also
Asp1, Glu11 and Glu22. Lys16 again engages in hardly any
interactions, while Lys28 interacts only with Glu22 and Asp23,
but only for around 10% of frames. The latter interaction is
believed to play a role in the conformational changes that
accompany aggregation of Ab42 into brils;62 the ability of
Pt(phen) to disrupt this may be an important aspect of its eﬀect
on peptide aggregation.
Fig. 4 illustrates the per-residue peptide secondary structure
of Pt-Ab16 and Pt-Ab42. N-terminal residues in Ab16 adopt coil
conformations most frequently, with small amounts of turn andTable 2 RMSF statistics for 300 K trajectories (A˚)a
Pt-Ab16 Pt-Ab42
Mean 3.61 7.49
SD 1.03 1.77
Min 2.32 4.41
Max 6.06 12.66
a Ca–Ca distances in Pt-Ab16 and Pt-Ab42 are used to interrogate the
tertiary structure of the peptides, as represented in the contact maps
in Fig. 2. In the shorter peptide, the longest inter-residue distances
occur for Asp1, with values in excess of 20 A˚ for residues Val12
through Lys16. Indeed there is little structure in the contact map:
close contact between Pt-binding residues 6 and 14 is apparent, while
the sequence between these is also restricted to relatively short
distances. The longer peptide exhibits more structure: Asp1 again has
the longest distances, most notably to amino acids in the CHC and
the extreme C-terminus. Longer distances are also found for the
sequences Ser8-Tyr10 with Asp23-Lys28. Short contact is found for
His6 with His14 and the residues between them, and also between
Phe19-Ala21 with Gly29-Gly33.
35092 | RSC Adv., 2019, 9, 35089–35097bend, while the region between the metal-binding sites (His6-
His14) adopts helical structure more frequently. In particular,
a-helical content is especially common from Glu11-Gln15 (up to
53% of simulation), while 3,10 helices are prevalent between
Ser8-His14 (up to 37%). This region also contains signicant
amounts of turn and bend (ca. 60%) structures centred on Ser8-
Gly9. C-terminal Gln15 and especially Lys16 are less structured,
although some a-helix structure is retained here.
Pt-Ab42 exhibits more varied secondary structure: only the
very terminal residues Asp1, Ala2 and Ala42 are predominantly
coil in form, whereas helical structures are apparent throughout
the remainder of the sequence. This is mostly 3,10 in character
for Glu3-Arg5, but a-helix accounts for over 50% of conforma-
tions in Val12-Val24, and over 80% of Lys28-Val36. Approxi-
mately 20% of conformations of Phe20-Glu22 and Val39-Ile41
adopt parallel b-sheet geometry, indicating that these residues
form through-space contacts for a signicant portion of the
trajectory. Turn/bend forms are also present, notably for Ser8-
Gly9 (62%), Val24-Gly25 (53%) and Gly37-Gly38 (57%). It is
clear from this that Pt-coordinated Ab forms numerous and
stable helical structures, rather more than is found for other
metals.59 It may be that this preference for helical structure is
related to the known inhibition of bril formation induced byFig. 2 Pt-Ab16 and Pt-Ab42 Ca distance matrices (A˚), demonstrating
close contacts (blue) between His6 and His14 due to Pt coordination,
as well as ween Phe19-Ala21 with Gly29-Gly33 in the larger peptide.
This journal is © The Royal Society of Chemistry 2019
Fig. 3 Salt bridge occurrence (%) from 300 K simulations indicating just one prevalent interaction in the smaller peptide (left), and two in the
larger one (right).
Fig. 4 Average secondary structure percentage, indicating signiﬁcant
bend, turn and some helical content in the smaller peptide (top), with
more helical and some b-strand content in the larger peptide (bottom).
Table 3 Pt-Ab16 secondary structure percentages
Helix Sheet Other
Pt-Ab16 32.5 0.01 67.4
Pt-Ab42 42.8 2.8 54.4
Paper RSC Advances
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View Article OnlinePt(phen), for example by reducing the propensity for this over
formation of the b-strands that are thought to act as the seeds
for aggregation.63This journal is © The Royal Society of Chemistry 2019Secondary structure percentages for the platinum-
coordinated peptides adopted at 300 K are shown in Table 3,
combining a/p/3,10 helices, parallel/antiparallel sheets, and
turn/bend/coil into single measures. As expected for an intrin-
sically disordered peptide, including sampling from high
temperatures in REMD, random coil/turn/bend conformations
form the largest category. These data show that Ab16 has almost
one-third of residues in helical orientation, but almost no b-
sheet, while Ab42 has signicantly more helical content as well
as a small amount of b-sheet.
Ramachandran maps for both Pt-Ab16 and Pt-Ab42 (Fig. 5)
are dominated by right-handed a-helical conformations, cen-
tred on (60,40), with smaller but noticeable populations of
poly-proline II (75, 150) and b-sheet (150, 160) structure,
as well as small amounts of le-handed helical structures.
Following the nomenclature of Hollingsworth and Karplus,63 we
see little evidence for g structures, but g0 at (80, +80) is
populated as part of the “bridge” region.
Table 4 reports statistics relating to the number of observed
hydrogen bonds: Pt-Ab16 has, on average, slightly less than ve
hydrogen bonds per simulation frame, the large standard
deviation indicating that these interactions are uxional, as
shown by congurations with no hydrogen bonds as well as
others with as many as fourteen. Only 6 hydrogen bonds persist
for more than 10% of simulation time, the most prevalent of
these, present for 34% of the trajectory, links His14 Nd–H with
backbone O of Glu11, which also H-bonds to backbone of Gln15RSC Adv., 2019, 9, 35089–35097 | 35093
Fig. 5 Ramachandran plot for Pt-Ab16 (left) and Pt-Ab42 (right) 300 K REMD simulation.
Table 4 Statistics of hydrogen bond occupation
Pt-Ab16 Pt-Ab42
Ave 4.7 11.7
SD 1.8 3.0
Min 14 25
Max 0 0
RSC Advances Paper
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View Article Online(18% of frames). O3 of Glu3 interacts with backbone N–H of
Phe4 for 33% of simulation. For Pt-Ab42 the values are larger
but the pattern is similar: the average of 11.7  3.0 incorporates
a range of between 25 and 0 hydrogen bonds. 26 interactions are
present for at least 10% of the simulation, including Glu11 O3 to
His14 Nd–H (48%), Gly29 backbone O to Gly33 N–H (37%), and
Glu11 backbone O to Gln15 backbone N–H (23%). The latter are
among numerous i+4 / i backbone–backbone interactions
associated with a-helix structure are observed (23 with at least
2% occupancy, Table S7†), mainly in the CHC and C-terminus.
20 i+3/ i hydrogen bonds, characteristic of 3,10-helices, areFig. 6 Representation of most populated clusters of Pt-Ab16 and Pt-Ab4
peptide backbone as ribbon (red ¼ helix, yellow ¼ sheet, blue ¼ turn, w
35094 | RSC Adv., 2019, 9, 35089–35097also observed along with 3 i+5/ i interactions that are char-
acteristic of p-helical structures, mainly in the C-terminus (see
Table S7† for full details).
As well as hydrogen bonds, stacking interactions between
peptide and phenanthroline ligand have been suggested to play
a role in specic binding and disruption of the structure and
aggregation of Ab. Potential interactions were sought by moni-
toring the shortest distance between Ca/Cb/Cg of each amino
acid and any carbon atom of the ligand. Variance within these
distances is large, but for Pt-Ab16 Tyr10 and His13 stand out as
being commonly found in proximity to the ligand, with average
distances of 6.86  3.43 A˚ and 7.16  2.45 A˚. 35% of frames
contain at least one atom–atom distance of less than 5 A˚
between Tyr10 and phen, and 9% have such contacts with
His13. The closest contact with Tyr10 consists of face-to-face p-
stacking with phenanthroline, with distance between ring
centroids ¼ 3.55 A˚ and angle between planes of 0.18. The
closest contact with His13 also exhibits stacking with the
ligand, albeit with larger separation and reduced co-planarity
(distance ¼ 3.81 A˚, angle ¼ 12.7). In contrast, Phe4 only2, with Pt(phen) shown as solid lines, coordinated His as wireframe, and
hite ¼ coil).
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinesporadically makes contact with the ligand, with less than 2% of
frames within 5 A˚, and average separation 14.91 A˚.
In contrast, in Pt-Ab42 only Phe4 forms persistent non-
covalent interactions with phenanthroline within the room
temperature REMD trajectory, with an average distance of 9.98
 4.61 A˚, and 15% of frames within 5 A˚. Tyr10 and His13 exhibit
longer averages (14.5 and 11.0 A˚) and fewer frames with close
contact (<1%). The closest contact of Phe4 is also parallel p-
stacking, with distance between ring centroids ¼ 4.02 A˚ and
angle between planes of 2.75. It seems, therefore, that the more
exible nature of the full-length peptide leads to more transient
stacking interactions than are observed in the truncated one
alone. Such interactions are nevertheless present with all
aromatic side chains, andmay play a role in binding of Pt(phen)
to the N-terminus as well as the conformations then adopted.
Clustering of room temperature trajectories gave rise to
sparsely populated clusters, with maximum population of 2.5%
and 1% for Pt-Ab16 and Pt-Ab42, respectively. Representative
structures of the most populated cluster for each are shown in
Fig. 6. Firstly, this demonstrates the stability of the
Pt(phen)(His)2 coordination mode, with imidazoles of His6 and
His14 approximately perpendicular to the plane of Pt(phen). In
common with the patterns noted above, Pt-Ab16 is mainly coil
in the N-terminus, with turn and a small helical element toward
the C-terminus. This structure also shows evidence of the non-
covalent interactions noted above, with both Tyr10 and His13
approximately 4.5 A˚ from phenanthroline in a slipped-parallel
stacked arrangement. More secondary structural elements are
apparent in Pt-Ab42, although here again the N-terminus is
relatively unstructured. Helical structure is observed for the
sequence Lys28-Val36, along with an antiparallel b-sheet con-
necting Phe20-Asp23 with Val39-Ala42, separated by turns cen-
tred on Val12 and Asn27. The phenanthroline is located in
a hydrophobic environment, with Leu34, Met35 and Val36 in
particular located close to the p-system, but in this particular
structure none of the aromatic residues discussed above are
found within 5 A˚ of the ligand.
Conclusions
Replica exchange molecular dynamics has been used to provide
enhanced sampling of the conformational freedom available to
the adduct formed between amyloid-b peptides and Pt(II)phe-
nanthroline. We report data both for the metal-binding N-
terminal sequence (Pt-Ab16) and for the complete peptide (Pt-
Ab42), each bound to Pt through His6 and His13. AMBER-style
forceelds for these systems were developed using the MCPB
approach for Pt, along with GAFF for the phenanthroline ligand.
The success of REMD in enhancing sampling is demonstrated
by exchange frequencies between simulations at diﬀerent
temperatures, ranging from 270 to 615 K, of between 0.15 and
0.2, and also by the fact that the entire ensemble includes
structures that are much more extended than those visited by
simulations at room/body temperature alone.
A key aspect of any such study is the suitability of the
methods used, which in this case means the forceeld and
solvent model. Parameters from Li andMerz's MCPB.pymethodThis journal is © The Royal Society of Chemistry 2019for Pt and coordinated atoms, along with GAFF for phenan-
throline ligand, reproduce known coordination geometry of
Pt(II) bound to two His residues. The ﬀ14SB forceeld used for
peptide here is the primary model in the AMBER suite, reported
to yield improved secondary structure content in small peptides
and NMR data for proteins in solution compared to previous
versions. However, a recent report64 suggests it may be imbal-
anced when comparing folded and disordered proteins: we
hope to explore the eﬀect of diﬀerent forceelds in future
studies. Another issue may be the use of an implicit solvent
model, chosen here for the enhanced sampling that it enables,
but which might also lead to imbalance in intramolecular over
intermolecular interactions. This approach is widely used in
study of intrinsically disordered proteins (see for instance65,66
for recent examples). Moreover, the radius of gyration we report
is in the range of values reported in literature, namely 9 to 13 A˚
with a mean of 11.4 A˚,67 which lends condence to the suit-
ability of the approach we have taken.
Extracting trajectories only for the temperatures closest to
300 K (299 and 304 K for Pt-Ab16 and Pt-Ab42, respectively)
allows us to assess the range of structures accessible to these
systems at physiologically relevant temperatures. Both systems
are found to be relatively compact: once the size of Pt(phen) is
accounted for, radius of gyration is similar to Cu, Zn and Fe
complexes. Secondary structure, particularly helical, is present
for both peptides: the full-length Ab42 especially has extensive
a- and 3,10-helices, most notably in the metal-binding region
and in the central hydrophobic core. A smaller but signicant
proportion of frames are found to be in b-strand form in resi-
dues toward the C-terminus. Of the possible salt bridges that
may form within Ab, relatively few are present for substantial
portions of trajectories: Glu3-Arg5 is the most common in both
systems. Asp23-Lys28, which has been implicated in bril
formation, is only populated for 10% of recorded frames.
Non-covalent interactions also play a role: hydrogen bonds,
especially those associated with helical structures, are very
common but also highly uxional: in both cases, frames with no
H-bonds at all are observed. Stacking interactions between
aromatic residues and phenanthroline are also observed,
especially for the shorter Pt-Ab16, where His6 and Tyr10 make
frequent contact with the ligand. In the larger peptide these
residues are less commonly found in proximity with the ligand,
whereas Phe4 is more commonly disposed in this way. Overall,
direct contact between aromatic amino acids and the phenan-
throline ligand is present in all simulations, and apparently
plays a signicant role in the ensemble of conformations
adopted by the adducts.
It is instructive to compare the results obtained here with
analogous data obtained for the free Ab42 peptide by Yang and
Teplow.33 We note that this used a diﬀerent forceeld
(parm99SB), so any comparisons can only be qualitative.
Compared to that work, we nd much more helical but notably
less turn and b-strand content than in the free peptide. This is
particularly evident around residues 10 to 20, for which the free
peptide's a-helical content is less than half of that found here,
while turn percentages for residues 23–26 reported to be as high
as 70% in the free peptide are reduced to half or less of thoseRSC Adv., 2019, 9, 35089–35097 | 35095
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View Article Onlinevalues once Pt(phen) is bound. Tertiary structure is also
aﬀected: turn structures highlighted for the N-terminus of the
free peptide are lost aer Pt binding, as are weaker contacts
between residues 6–8 with 23–28, although other contact
between the CHC and residues 30–36 are common between
both simulations. Although this is far from conclusive, the
global eﬀect on peptide conformation of Pt(phen) binding
through just two N-terminal residues is striking, and may shed
new light on the origin of its observed anti-aggregation eﬀects.Data statement
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